GRANULES PHARMS FDA Approval ANDA 210424

ANDA 210424

GRANULES PHARMS

FDA Drug Application

Application #210424

Application Sponsors

ANDA 210424GRANULES PHARMS

Marketing Status

Prescription001

Application Products

001TABLET;ORAL0.2MG0METHYLERGONOVINE MALEATEMETHYLERGONOVINE MALEATE

FDA Submissions

UNKNOWN; ORIG1AP2018-05-15STANDARD

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAB

CDER Filings

GRANULES PHARMS
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 210424
            [companyName] => GRANULES PHARMS
            [docInserts] => ["",""]
            [products] => [{"drugName":"METHYLERGONOVINE MALEATE","activeIngredients":"METHYLERGONOVINE MALEATE","strength":"0.2MG","dosageForm":"TABLET;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"05\/15\/2018","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"STANDARD","inserts":"[]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2018-05-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.